XML 21 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Basis of Presentation and Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
3.
Basis of Presentation and Summary of Significant Accounting Policies
 
The Summary of Significant Accounting Policies included in the Company's Form
10
-K for the year ended
December 31, 2016,
filed with the Securities and Exchange Commission on
March 31, 2017
have
not
materially changed, except as set forth below.
 
Basis of Presentation
 
The accompanying unaudited interim condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information as found in the Accounting Standard Codification (“ASC”) and Accounting Standards Updates (“ASUs”) of the Financial Accounting Standards Board (“FASB”), and with the instructions to Form
10
-Q and Article
10
of Regulation S-
X
of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements of the Company include all normal and recurring adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered necessary to present fairly the Company’s financial position as of 
June 
30,
2017,
its results of operations for the
three
and
six
months ended
June 
30,
2017
and
2016
and cash flows for the
six
months ended
June 
30,
2017
and
2016.
Operating results for the
six
months ended 
June 
30,
2017
are
not
necessarily indicative of the results that
may
be expected for the year ending
December 
31,
2017.
The unaudited interim condensed consolidated financial statements presented herein do
not
contain the required disclosures under GAAP for annual financial statements. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements and related notes as of and for the year ended
December 
31,
2016
filed with the SEC on Form
10
-K on
March 31, 2017.
 
Use of Estimates
 
The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date the financial statements and reported amounts of expense during the reporting period. Actual results could differ from those estimates. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the unaudited condensed consolidated financial statements, actual results
may
materially vary from these estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited condensed consolidated financial statements in the period they are deemed necessary.
 
Cash and Cash Equivalents and Certificate of Deposit
 
The Company considers any highly liquid investments, such as money market funds, with an original maturity of
three
months or less to be cash and cash equivalents. The Company's certificate of deposit has a maturity greater than
three
months but within
one
year of the date of purchase. This certificate of deposit is classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.
 
Fair Value of Financial Instruments
 
The carrying amounts of the Company’s financial instruments, including cash equivalents, certificate of deposit, accounts payable, and accrued expenses approximate fair value due to the short-term nature of those instruments. As of each of
June 
30,
2017
and
December 
31,
2016,
the fair value of the Company’s outstanding convertible notes was approximately
$2.6
million. The fair value of the convertible notes is determined using a binomial lattice model that utilizes certain unobservable inputs that fall within Level
3
of the fair value hierarchy.
 
Offering Costs
 
Offering costs consist principally of legal costs incurred through the balance sheet date related to the Company’s private placement financings and are recognized in other assets on the consolidated balance sheet. At
June 
30,
2017
and
December 31, 2016,
there were
$93,000
and
$0.2
million in deferred offering costs, respectively. These costs are either expensed upon completion of the related financing or offset against the proceeds of the offering, depending upon the accounting treatment of the offering.
 
Intangible Assets and Goodwill
 
In connection with the Merger, the Company acquired indefinite-lived In-Process Research and Development Assets (“IPR&D”) RES-
529
and RES-
440,
with estimated fair values of
$8.6
million and
$1.0
million, respectively, and recognized
$6.9
million in goodwill. In the
third
quarter of
2016,
the IPR&D asset associated with RES-
440
was abandoned and written down to
$0.
RES-
529
and goodwill are assessed for impairment on each of
October 1
of the Company’s fiscal year or more frequently if impairment indicators exist. The Company has a single reporting unit and all goodwill relates to that reporting unit. There were
no
impairment indicators or impairments to RES-
529
or goodwill during the
three
and
six
months ended
June 30, 2017.
 
Net Income (Loss) Per Common Share
 
For the
three
months ended
June 30, 2017,
the Company used the
two
-class method to compute net income per common share because the Company has issued securities (Series A convertible preferred stock) that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by any dividends earned during the period. The remaining earnings (undistributed earnings) are allocated to common stock and the Series A convertible preferred stock to the extent that the Series A convertible preferred stock
may
share in earnings as if all of the earnings for the period had been distributed. The total earnings allocated to common stock is then divided by the number of outstanding shares to which the earnings are allocated to determine the earnings per share. The
two
-class method is
not
applicable during periods with a net loss, as the holders of the convertible preferred stock have
no
obligation to fund losses.
 
Diluted net income (loss) per common share is computed under the
two
-class method by using the weighted-average number of shares of common stock outstanding, plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options, unvested restricted stock, warrants, and convertible debt. In addition, the Company analyzes the potential dilutive effect of the outstanding convertible preferred stock under the “if-converted” method when calculating diluted earnings per share, in which it is assumed that the outstanding convertible preferred stock converts into common stock at the beginning of the period or when issued, if later. The Company reports the more dilutive of the approaches (
two
class or “if-converted”) as its diluted net income per share during the period.
 
For the periods in which the Company reported a net loss, there was
no
dilutive effect under either the
two
-class or “if-converted” method. For the
three
months ended
June 30, 2017,
the Company presented diluted net income per common share using the
two
-class method, which was more dilutive than the “if-converted” method.
 
 
For purposes of calculating diluted loss per common share, the denominator includes both the weighted average common shares outstanding and the number of common stock equivalents if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include stock options, unvested restricted stock awards and warrants using the treasury stock method. The diluted loss per common share calculation is also affected by the assumed exercise of the liability classified warrants using the treasury stock method, if dilutive, and adjusting the numerator for the change in fair value of the warrant liability. In addition, the Company considers the potential dilutive impact of its convertible debt instruments using the "if-converted" method.
 
 
The following table sets forth the computation of basic and diluted earnings per share:
 
 
 
Three Months Ended June 30,
 
 
Six Months Ended June 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Basic net income (loss) per common share calculation:
                               
Net income (loss)
  $
20,387,741
    $
(3,806,194
)
  $
(8,251,037
)
  $
(10,029,359
)
Accretion of Series A cumulative preferred dividends
   
(487,460
)
   
     
(546,305
)
   
 
Undistributed earnings allocated to participating securities
   
(10,416,153
)
   
     
     
 
Net income (loss) attributable to common stockholders
  $
9,484,128
     
(3,806,194
)
   
(8,797,342
)
   
(10,029,359
)
                                 
Weighted average shares outstanding, basic
   
10,828,063
     
10,263,703
     
10,582,521
     
10,130,042
 
Net income (loss) per share of common stock, basic
  $
0.88
    $
(0.37
)
  $
(0.83
)
  $
(0.99
)
                                 
Diluted net income (loss) per common share calculation:
                               
Net income (loss) attributable to common stockholders
  $
9,484,128
     
(3,806,194
)
   
(8,797,342
)
   
(10,029,359
)
Change in fair value of warrant liability
   
(23,387,850
)
   
     
(10,468,176
)
   
 
Diluted net loss
  $
(13,903,722
)
   
(3,806,194
)
   
(19,265,518
)
   
(10,029,359
)
                                 
Weighted average shares outstanding, basic
   
10,828,063
     
10,263,703
     
10,582,521
     
10,130,042
 
Shares from dilutive warrants
   
3,044,569
     
     
1,756,865
     
 
Weighted average shares outstanding, diluted
   
13,872,632
     
10,263,703
     
12,339,386
     
10,130,042
 
Net income (loss) per share of common stock, diluted
  $
(1.00
)
  $
(0.37
)
  $
(1.56
)
  $
(0.99
)
 
 
The following potentially dilutive securities outstanding as of
June 
30,
2017
and
2016
have been excluded from the computation of diluted weighted average shares outstanding, as they would be anti-dilutive:
 
 
 
 
June 30,
 
 
 
2017
 
 
2016
 
Convertible debt
   
774,886
     
429,161
 
Convertible preferred stock
   
10,449,338
     
 
Common stock warrants
   
457,721
     
461,209
 
Stock options
   
2,525,989
     
1,797,812
 
Unvested restricted stock awards
   
6,132
     
12,273
 
     
14,214,066
     
2,700,455
 
 
Amounts in the table reflect the common stock equivalents of the noted instruments.
 
 
Recent Accounting Pronouncements
 
In
July 
2017,
the FASB issued ASU
2017
-
11,
Earnings Per Share (Topic
260
); Distinguishing Liabilities from Equity (Topic
480
); Derivatives and Hedging (Topic
815
): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception.
The
first
part of this update addresses the complexity of accounting for certain financial instruments with down round features and the
second
part addresses the complexity of distinguishing liabilities from equity. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2018
and interim periods within those years. The Company is currently evaluating the potential impact of the adoption of this standard on its consolidated results of operations, financial position and cash flows and related disclosures.
 
In
May 2017,
the FASB issued ASU
No.
2017
-
09,
Modification Accounting for Share-Based Payment Arrangements
, which amends the scope of modification accounting for share-based payment arrangements. The ASU provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC
718.
Specifically, an entity would
not
apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2017
and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company does
not
expect this new guidance to have a material impact on its condensed consolidated financial statements.
 
In
March 
2016,
the FASB issued ASU
2016
-
09,
Compensation – Improvements to Employee Share-Based Payment Accounting
, which simplifies several aspects of the accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The guidance is applicable to public business entities for fiscal years beginning after
December 15, 2016
and interim periods within those years. The Company adopted this standard in
2017
by electing to account for forfeitures in the period that they occur. Under ASU
2016
-
09,
accounting changes adopted using the modified retrospective method must be calculated as of the beginning of the period adopted and reported as a cumulative-effect adjustment. As a result, the Company recognized cumulative-effect adjustment of approximately
$1,000
on
January 1, 2017.
 
In
February 2016,
the FASB issued ASU
2016
-
02,
Leases (Topic
842
)
. The FASB issued the update to require the recognition of lease assets and liabilities on the balance sheet of lessees. The standard will be effective for fiscal years beginning after
December 
15,
2018,
including interim periods within such fiscal years. The ASU requires a modified retrospective transition method with the option to elect a package of practical expedients. Early adoption is permitted. The Company is currently evaluating the potential impact of the adoption of this standard on its consolidated results of operations, financial position and cash flows and related disclosures.